ETF Evaluator:
Robo Global® Hlthcare Tech & Innovt ETF ()
Follow This ETF
(as of Aug 26)
Best Performing in Health Over the Last Year
| 129.4% | Virtus LifeSci Biotech Clinical Trls ETF (BBC) |
| 94.1% | ALPS Medical Breakthroughs ETF (SBIO) |
| 88.4% | F/m Emerald Life Sciences Innovation ETF (LFSC) |
| 72.5% | State Street® SPDR® S&P® Biotech ETF (XBI) |
| 65.8% | State Street® SPDR® S&P® PhrmctlsETF (XPH) |
Risk
Index
Risk
Index
ETF Details
Robo Global® Hlthcare Tech & Innovt ETF Overview
Robo Global® Hlthcare Tech & Innovt ETF (HTEC) is a passively managed Sector Equity Health exchange-traded fund (ETF). Robo Global launched the ETF in 2019.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index.
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.
About Robo Global® Hlthcare Tech & Innovt ETF (HTEC)
There are 4 members of the management team with an average tenure of 5.15 years: Andrew Serowik (2019), Gabriel Tan (2021), Todd Alberico (2021) and Brian Cooper (2022). Management tenure is more important for actively managed ETFs than passive index ETFs.
The ETF has 2 primary benchmarks: S&P 500 (TR) (1970) index with a weighting of 100% and ROBO Gbl Healthcare Tech & Innov PR USD index with a weighting of 100%. Robo Global® Hlthcare Tech & Innovt ETF has 66 securities in its portfolio. The top 10 holdings constitute 22.1% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a nondiversified fund. The ETF is not considered to have an ESG focus with its investment selection and management.
Robo Global® Hlthcare Tech & Innovt ETF is part of the Equity global asset class and is within the Sector Equity ETF group. Robo Global® Hlthcare Tech & Innovt ETF has 18.4% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 81.5% There is 18.4% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Robo Global® Hlthcare Tech & Innovt ETF has 0.2% of the portfolio in cash.
Assets Under Management
The fund has $69 million in total assets, which is below the $1 billion average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
HTEC Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Robo Global® Hlthcare Tech & Innovt ETF expense ratio is above average compared to funds in the Health category. Robo Global® Hlthcare Tech & Innovt ETF has an expense ratio of 0.68%, which is 31% higher than its category average, making the fund expense ratio grade a F. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. Robo Global® Hlthcare Tech & Innovt ETF has a portfolio turnover rate of 38%, which indicates that it holds its assets around / 0.0 years. By way of comparison, the average portfolio turnover is 45% for the Health category.
Recently, in the month of July 2026, Robo Global® Hlthcare Tech & Innovt ETF returned 2.8%, which earned it a grade of A, as the Health category had an average return of -0.1%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.
Robo Global® Hlthcare Tech & Innovt ETF has a trailing yield of 0.90%, which is below the 1.10% category average.
The fund normally distributes its income annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
Robo Global® Hlthcare Tech & Innovt ETF Grades
Year to date, the ETF has returned 8.3%, 1.4 percentage points worse than the category, which translates into a grade of C. The fund has returned 38.3% over the past year (grade of C), 8.2% over the past three years (grade of C) and -3.9% per year over the past five years (grade of D).
For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about Robo Global® Hlthcare Tech & Innovt ETF, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
HTEC Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| HTEC Return (NAV) | 2.8% | 15.2% | 38.3% | 8.2% | -3.9% | na |
| HTEC Return (Price) | 3.2% | 15.1% | 39.0% | 8.3% | -3.9% | na |
| NAV +/- Price Return | -0.376% | 0.030% | -0.696% | -0.143% | 0.006% | na |
| Health Avg | -0.1% | 11.2% | 36.9% | 9.9% | 1.6% | 8.7% |
| HTEC Grade (NAV) | A | B | C | C | D | na |
| +/- Category (NAV) | 2.9% | 3.9% | 1.4% | -1.8% | -5.5% | na |
| HTEC Tax-Cost Ratio | na | na | 0.4% | 0.1% | 0.1% | na |
HTEC Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| HTEC Return (NAV) | 8.3% | 24.0% | 2.8% | -3.0% | -33.6% | -0.1% | 65.2% | na | na | na | na |
| HTEC Return (Price) | 8.9% | 23.9% | 2.7% | -2.9% | -33.7% | -0.2% | 65.0% | na | na | na | na |
| NAV +/- Price Ret | 0.071% | -0.003% | -0.049% | -0.031% | 0.005% | 0.571% | -0.003% | na | na | na | na |
| Health Avg | 9.7% | 21.8% | 0.1% | 2.2% | -16.3% | 4.3% | 30.5% | 25.4% | -1.5% | 26.5% | -10.2% |
| HTEC Grade (NAV) | C | C | B | F | F | D | A | na | na | na | na |
| +/- Category | -1.4% | 2.2% | 2.7% | -5.3% | -17.3% | -4.4% | 34.7% | na | na | na | na |
| Risk Measures | |
| Beta: | 1.22 |
| R-Squared: | 52% |
| Standard Deviation: | 21.4% |
| Category Risk Index: | 1.07 |
| Category Risk Rating: | Above Average |
| Total Risk Index: | 1.75 |
| Total Risk Rating: | High |
| Portfolio Characteristics | |
| Yield: | 0.9% |
| Total Assets: | $ 69 Mil |
| Share Class Assets: | $ 69 Mil |
| Turnover: | 38.0% |
| Expense Ratio: | 0.68% |
| Index Fund: | Yes |
| Index Tracked: | S&P 500 (TR) (1970) |
| Index Weighting: | 100% |
| Leveraged: | No |
| Socially Responsible Fund: | No |
| Capital Gains Distribution Frequency: | |
| Income Distribution Frequency: | Annually |
Management Team
| Number of Managers: 4 | |||
| Longest Tenure: 7.1 years | |||
| Average Tenure: 5.1 years | |||
| Managers (Year): Serowik Andrew (2019), Tan Gabriel (2021), Alberico Todd (2021), Cooper Brian (2022) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 66 |
| % in Top 10 Holdings: | 22.1% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 18.4% |
Portfolio Allocation |
|
| Domestic Stock: | 81.5% |
| Foreign Stock: | 18.4% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.2% |
Purchase Information
| Legal Structure: | Open Ended Investment Company |
| Fund Family: | Robo Global |
| Phone Number: | 855-456-7626 |
| Website: | www.exchangetradedconcepts.com |
| Inception Date: | June 24, 2019 |
Expenses and Fees
| Expense Ratio (%): | 0.68% (Rating: Above Avg) |
| Category Average Expense Ratio (%): | 0.52% |
